Schedule 13G ownership disclosure

Coya Therapeutics Inc

Security class unavailable · CUSIP: 22407B108

Event date: 2022-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-000441
Form type
SC 13G
Filer
Coya Therapeutics, Inc.
CIK
CIK 1835022
Filed
Jan 05, 2023
Reporting period
Dec 29, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub